Panel Discussion | TAVR | Impact of New Indications and Competition

Tuesday, March 11, 2025

9:00 AM – 9:20 AM ET

Panel Moderator(s)

Lawrence Biegelsen, MBA

Managing Director Medical Supplies & Devices
Wells Fargo
Short Hills, New Jersey, United States

Disclosure(s): No financial relationships to disclose
Rick Wise, CFA

Research Analyst
Stifel
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Rafael Cavalcante, MD, PhD

Vice President, Medical Affairs
Boston Scientific
Newton, Massachusetts, United States

Disclosure information not submitted.
Nina Goodheart, MBA

SVP & President
Structural Heart & Aortic - Medtronic
Doylestown, Pennsylvania, United States

Disclosure(s): medtronic.: Employee (Ongoing)
Eberhard Grube, MD, MSCAI

Head CIIC
University Hospital Bonn
Bonn, Nordrhein-Westfalen, Germany

Disclosure information not submitted.
Duane Pinto, MD, MPH, FSCAI

Chief Medical Officer
JenaValve
Boston, Massachusetts, United States

Disclosure(s): AriaCV: Consultant (Ongoing); JenaValve Technology Inc: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Jeffrey J. Popma, MD

CRF
Newton, Massachusetts, United States

Disclosure(s): Medtronic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Michael J. Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

Disclosure(s): BSCI: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Lars Sondergaard, MD

Chief Medical Officer
Abbott Structural Heart
Santa Clara, California, United States

Disclosure(s): Abbott Structural Heart, Medtronic, Boston Scientific: Employee (Ongoing)
Mark A. Turco, MD

CEO & President
JC Medical and Genesis MedTech
Providence, Rhode Island, United States

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)
Larry L. Wood

Corporate VP & Group President, Transcatheter Heart Valves & Surgical Structural Heart
Edwards Lifesciences, LLC
Irvine, California, United States

Disclosure(s): Edwards Lifesciences LLC: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):

Lawrence Biegelsen, MBA: No financial relationships to disclose

Rick Wise, CFA: No financial relationships to disclose

Nina Goodheart, MBA: medtronic.: Employee (Ongoing)

Duane Pinto, MD, MPH, FSCAI: AriaCV: Consultant (Ongoing); JenaValve Technology Inc: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Jeffrey J. Popma, MD: Medtronic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Michael J. Reardon, MD: BSCI: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Lars Sondergaard, MD: Abbott Structural Heart, Medtronic, Boston Scientific: Employee (Ongoing)

Mark A. Turco, MD: No financial relationships to disclose

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Larry L. Wood: Edwards Lifesciences LLC: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)